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Abdominal TB usually presents with 
nonspecific findings and may thus 
m.,mw a multitude of gastrointestinal 
disorders. Abdominal tuberculosis may 
therefore present as large and palpable 
intra-abdominal masses usually arising 
from lymphadenopathy which may mimic 
lymphomas and other malignancies. We 
present the report of a patient with 
suspected abdominal malignancy 
diagnosed with abdominal tuberculosis. 
METHODS 
The case records of a patient who 
presented at the university of Port 
Harcourt Teaching hospital, medical unit 
with an abdominal mass diagnosed with 
abdominal Tb and a review of the 
literature utilizing google, PubMed, 
medline and existing literature was 
utilized. 
RESULTS 
Abdominal Tb is a maJor contributor to 
the burden of EPTb with reports of 
increasing incidence. Based on the wide 
spectrum of symptoms and signs 
originating from various parts of the 
abdomen the disease may be 
misdiagnosed. 
CONCLUSION 
In conclusion abdominal Tb still remains 
a disease which should be kept in mind 
and considered by clinicians in Nigeria 
as it is a great mimic and may be hard-to-
diagnose. A high index of suspicion and 
the use of ancillary, radiologic and 
surgical techniques should be employed 
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INTRODUCTION 
With the recent resurgence of tuberculosis (Tb) 
infections 1 and its combination with 
HIV/AIDs; the interest in extra-pulmonary 
tuberculosis (EPTb) disease such as 
abdominal (Tb) has been revived.1-4 
Abdominal Tb is a major contributor to the 
burden of EPTb as it has been shown to 
account for 11% of all cases of EPTb2• The 
increasing prevalence of extra-pulmonary and 
abdominal Tb in high burden countries like 
Nigeria is illustrated by the report of a study4 
in Enugu Nigeria which documented a fourfold 
increase in the cases of EPTb from 2000-2004 
to 2005-2009. The contribution ofHIV/AIDs to 
the rising prevalence of EPTb is also 
demonstrated in a study5 from Benin South-
South Nigeria which found a TB HIV 
prevalence of 33.9% and a 21.4% incidence of 
EPTb in HIV patients. 
Abdominal TB usually presents with 
nonspecific findings and may thus mimic 
a multitude of gastrointestinal disorders; as 
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Figures 1 and 2. Abdominal CT Scan 
showing the intraabdominal mass 
The chest X-ray was a normal study. The 
patients erythrocyte sedimentation rate (ESR) 
was >150mm/h, while Heamoglobin was 8g/dl 
with a lymphocytosis on blood count. He was 
HIV 1 & 11- Seronegative. His fasting blood 
sugar was 14mmol/l. 
A diagnosis of abdominal Tuberculosis with 
abdominal lymphadenopathy was made. The 
patient was the commenced on first line anti 
tuberculosis regimen of rifampicin, isoniazid, 
pyrazinamide and ethambutol in line with the 
National guidelines for tuberculosis 
treatmene2 with a 2 months intensive phase 
and 4 months continuation phase with 
isoniazid and rifampicin under DOTs 
supervision at the DOTs centre in our hospital. 
Patients diabetes mellitus was controlled with 
insulin. 
The treatment was monitored with abdominal 
girth, repeat ultrasonography, Heamoglobin, 
ESR and weight trends. Within the first four 
weeks of treatment the patient's weight 
improved from 48kg to 56kg, abdominal girth 
reduced from 106cm to 84cm while ESR 
reduced from >150mm/hr to 48mm/hr. A 
repeat abdominal scan revealed a reduction in 
abdominal mass. The patient completed the 
treatment regimen under DOTs and was 
declared cured. 
DISCUSSION 
In spite of the global reduction in prevalence of 
abdominal Tb there has been a recent increase 
in the incidence of Abdominal Tb in developing 
countries.1-3 This recent upsurge which has 
been reported by numerous studies, 2'4'5 has 
been associated with HIV infection which 
increases the risk of extra-pulmonary Tb.1'4'5'9 
Other risks for the observed upsurge is the 
increasing number of multidrug-resistant 
strains of M. Tuberculosis1 and the use of 
unpasteurized milk in some in low resource 
countries13• The patient in this report took 
unpasteurized milk and this may be the major 
risk for the development of abdominal 
tuberculosis from M Bovis in the patient as he 
was HIV negative. 
Other risk factors for abdominal Tb which 
have been reported in other studies6' 14 include 
diabetes mellitus, liver cirrhosis and end stage 
renal disease. Chou et al6 in Taiwan reported 
diabetes as the risk factor in 8.8% of patients 
their study. They6 also noted that patients with 
diabetes had more positive AFB from their 
abdominal samples. The patient in this report 
was diabetic and had a positive AFB test from 
his ascitic fluid in keeping with the 
observations of Chou et al. 
The presence of diabetes mellitus which is an 
immunosuppressive state in this patient may 
have been the major risk for the development 
of the disease as the features occurred after his 
diabetic diagnosis. 
Abdominal Tb can be seen in all ages and socio-
economic groups with an equal sex incidence, 
in spite of reports of higher female 
prevalence. 2'15 lt is however thought to be more 
common in young adults between ages 21-40 
yrs and at age 50-55yrs for white patients. 2'15 
This view has been supported by the reports of 
Ohanaka et ae6 in Benin Nigeria who reported 
an age range of 20-55 years, mean age of 30yrs 
and a female to male ratio of7:1. Akinkuolie et 
al17 from south west Nigeria reported a mean 
age of 28 years and female to male ratio of 
1.22:1; while Chou et al6 in Taiwan reported a 
mean age 55years and a female to male ratio of 
1.26;1. The patient in this study was a middle 
aged man. 
The presentation of abdominal tuberculosis 
varies as it can affect any structure in the 
abdomen from the peritoneum, lymph nodes, 
intestines and organs like the liver or 
spleen. 2'15 Abdominal Tb is thus considered as 
a great mimic for many abdominal conditions 
and can therefore result in misdiagnosis if not 
suspected. 2'7'8'15 A variety of studies2'6' 15-18 have 
shown that Abdominal pain, abdominal 
fullness, anorexia, ascites, fever and weight 
loss are the common symptoms in abdominal 
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tuberculosis. Other features which may be 
present are symptoms of an acute abdomen, 
chronic diarhoea, abdominal distention and 
large intraabdominal mass.2'6'11'18 Our patient 
presented with progressively increasing 
abdominal swelling, weight loss, low grade 
fever and night sweat which are some of the 
key features in abdominal Tb. 
The challenge in making an accurate clinical 
diagnosis of abdominal Tb may result in 
delayed diagnosis with the attendant 
consequences of morbidity and mortality. 2'6'8'15 
Therefore a high index of suspicion, good 
clinical evaluation and the use of surgical 9'18'19 
radiologic10'20 microbiological and histologic2'9'17 
tools should be utilized to arrive at the 
diagnosis when it is suspected. 
The patient in this report had key elements in 
his history such as the use of unpasteurized 
milk in addition to the clinical features of 
fever, weight loss and night sweats which 
increased the suspicion. The use 
unpasteurized milk was the key etiologic 
factor in this patient especially in the absence 
of any pulmonary involvement to suggest a 
secondary infection process. It has been found 
that many patients with abdominal 
Tuberculosis may have coexisting pulmonary 
disease, however the presence of abnormal 
chest radiographs are not always indicative of 
active disease as has been shown in many 
studies. A report by Nail14 indicated that while 
abnormal chest radiograph was found in 48% 
of cases only 14% of the subjects had active 
pulmonary tuberculosis. Akinkuolie et al17 in 
Nigeria also reported that though 25% of 
patients in their series had abnormal chest x-
rays only 14.3% had active pulmonary disease; 
a similar trend was also documented by Chou 
et al6 in Taiwan where 47% had abnormal 
chest xrays while only 23% had active disease. 
Abdominal tuberculosis may thus occur in the 
absence of active pulmonary disease as seen in 
our patient. 
The history, aetiologic factors and the pattern 
of presentation of our patient with large 
conglomerate of lymphodal masses explains 
the absence of any pulmonary involvement as 
the presence of hypertrpophic tubercular 
lymphadenopathy suggests drainage to the 
mesenteric and omental nodes as a result of 
primary ingestion of mycobacterium bovis 
from unpasteurized milk. 10 
Other ancillary investigations such as full 
blood count, ESR and serum albumin which 
may show aneamia, lymphocytosis and 
hypoalbuminemia may also give a non specific 
pointer to the presence of Tb. The patient in 
this case had aneamia, lymphocytosis and 
markedly elevated ESR. The elevation ofESR 
in abdominal Tb patients has also been 
reported in a series from Nigeria17 where 89% 
of the subjects had elevated ESR. An elevated 
ESR may therefore be an supplementary 
pointer to the presence of abdominal 
tuberculosis in patient with abdominal 
features of uncertain etiology. 
Radiologic evaluation is also important in 
making a diagnosis of abdominal 
tuberculosis.10 A management algorithm10'21 
for abdominal Tb suggest the use of abdominal 
ultrasound as an initial screening test 
followed by contrast enhanced CT scan when 
ultrasound does not indicate a significant 
finding10'20 The simple abdominal ultrasound 
can show ascites, peritoneal involvement and 
the presence of enlarged lymph nodes and 
masses or enlargement from other organs 
while the CT Scan can give more detail to 
ultrasound findings and even identify 
abnormalities that ultrasound may miss. The 
patient in this case had abdominal ultrasound 
and CT scan which identified a mass of 
lymphoid origin with complicating 
hydronephrosis. Other investigations such as 
contrast barium studies are also useful for 
intestinal tract disease.10 Imaging studies also 
provide a guide for surgical procedures such as 
fine needle aspiration cytology(FNAC) and 
tissue biopsies which are needed to obtain 
tissue for bacteriologic and histological 
diagnosis. It is therefore advocated that 
radiologic modalities should be utilized 
optimally in cases where abdominal Tb IS 
suspected in order to achieve a diagnosis. 
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Though ancillary and radiologic test are 
important in the diagnosis of abdominal 
tuberculosis they are not the gold standard or 
conclusive diagnostic tools, as it is important 
to employ bacteriological and histological tests 
which will identify the presence of AFB, 
Mycobacterium and the classic granuloma 
pattern of mycobacterium infection. 2'10'15'17 It is 
recommended that when samples are required 
for histologic and bacteriologic diagnosis 
methods which are less invasive should be 







15 The non invasive procedures might 
include a diagnostic paracentesis of ascitic 
fluid for macroscopic, chemical and 
bacteriologic analysis. Tubercular ascitic fluid 
usually has protein more than 3 g/dL, with a 
total cell count of 150-4000/~L and consists 
predominantly of lymphocytes. 10 The ascitic 
fluid to blood glucose ratio is less than 0.96 and 
serum ascitic albumin gradient is less than 1.1 
g/dL.10 The identification of AFB in ascitic fluid 
on smear and culture is low as staining for acid 
fast bacilli is positive in less than 3% of cases 
and a positive culture is seen in only 20% of 
cases. 10 The patient in this report had positive 
AFB smear of his ascitic fluid indicating the 
presence of mycobacteria. The fact that the 
patient was diabetic may also have increased 
the chance of a positive AFB smear as reported 
in another study6 where diabetes was a 
positive factor for the identification of AFB in 
ascitic fluid. Another study in Nigeria17 also 
reported a higher rate of 29% positive AFB 
sample in ascitic fluid for patients with 
abdominal tuberculosis. Theses results 
indicate that ascitic fluid analysis should be 
performed in all patients with abdominal Tb 
and ascites. 
A culture of the ascitic fluid was not done in 
this study due to absence of a functional Tb 
culture reference laboratory at our center and 
the average turnaround time culture results 
which is 8-12 weeks12• Other tests which can 
be performed on ascitic fluid include adenosine 
deaminase (ADA) levels which are elevated in 
tubercular ascites with serum ADA level above 
54 U/L, ascitic fluid ADA level above 36 U/L 
and an ascitic fluid to serum ADA ratio more 
than 0.98.10 It should however be noted that in 
cases of co-infection with Hrv, ascitic ADA 
levels can be normal or low and falsely high 
values can be seen in malignant ascites. There 
was no capacity to perform ADA in our center. 
Other tests which can be carried out to obtain 
tissue and samples in abdominal Tb include a 
peritoneoscopy, laparoscopy, peritoneal biopsy 
and FNAC of lymph nodes or masses. The 
histology from these samples is expected to 
show the classic caseous granuloma of 
tuberculosis. The above methods are useful as 
the identification of AFB and histological 
patterns suggestive of Tb granuloma provide 
some certainty as to the bacterial etiology 
especially in low resource settings like ours 
where the capacity for culture and other 
genetic based testing to identify Tb is limited. 
This therefore makes it imperative for the use 
of other diagnostic tools which include genetic 
testing like gene Xpert-RIF and LPA in 
Nigeria beyond the current limited use of these 
tools for sputum samples in pulmonary Tb. We 
therefore advocate that testing for Xpert-RIF 
in Nigeria should be expanded to include other 
biologic samples like ascitic fluid in order to 
improve the diagnostic yield and capacity in 
abdominal Tb. 
Once abdominal Tb is diagnosed early 
treatment should be commenced in order to 
prevent complications and reduce mortality. 
Treatment should be commenced using the 
standard regimen for susceptible 
extrapulmonary tuberculosis in the country12 
consisting of rifampicin, isoniazid, 
ethambutol, and pyrazinamide in the 
intensive phase and a continuation phase of 
isoniazid and rifampicin. Patients with drug 
resistant abdominal Tb should be managed in 
line with the regimen for drug resistant 
tuberculosis in the country. 22 All patients 
should be under Directly observed therapy 
(DOT) as it ensures good treatment outcome. 
In conclusion abdominal Tb still remains a 
disease which should be kept in mind and 
considered by clinicians in Nigeria as it is a 
great mimic and may be hard-to-diagnose. A 
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high index of suspicion and the use of ancillary, 
radiologic and surgical techniques should be 
employed in order to make a correct and 
prompt diagnosis. 
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